Detalhe da pesquisa
1.
Does metformin reduce the risk of cancer in obesity and diabetes? A systematic review and meta-analysis.
Diabetes Obes Metab
; 26(5): 1929-1940, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38389430
2.
Cancer Outcomes Among Prediabetes and Type 2 Diabetes Populations With Dietary and Physical Activity-based Lifestyle Interventions.
J Clin Endocrinol Metab
; 108(8): 2124-2133, 2023 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36869709
3.
Sodium-glucose cotransporter-2 inhibitors and cancer outcomes: A systematic review and meta-analysis of randomized controlled trials.
Diabetes Res Clin Pract
; 198: 110621, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36921905
4.
Do GLP-1 Receptor Agonists Increase the Risk of Breast Cancer? A Systematic Review and Meta-analysis.
J Clin Endocrinol Metab
; 106(3): 912-921, 2021 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33248445
5.
Response to Letter to the Editor From Stumpf et al: Cancer Outcomes Among Prediabetes and Type 2 Diabetes Populations With Dietary and Physical Activity-Based Lifestyle Interventions.
J Clin Endocrinol Metab
; 108(11): e1461-e1462, 2023 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37170836